Physician and professional caregiver perspectives on meaningful change in agitation behaviors in Alzheimer's dementia: Insights from qualitative interviews [0.03%]
阿尔茨海默病痴呆患者焦虑行为有意义的改变：定量分析的见解
Jessica Smith,Brian Talon,Ana Martinez et al.
Jessica Smith et al.
Background: Agitation is a common neuropsychiatric symptom of Alzheimer's dementia. Limited qualitative evidence is available to characterize the clinical meaningfulness of changes in agitation behaviors, as assessed by t...
Editorial: Lifestyle and healthy aging to prevent cognitive decline and dementia [0.03%]
社论：生活方式与健康老龄化以预防认知衰退和痴呆症
Kristin R Krueger,Mathieu Hainselin,Ayse Kuspinar et al.
Kristin R Krueger et al.
Correction: Dementia-related stigma in physicians: a scoping review of stigma-reduction interventions [0.03%]
关于医师痴呆病相关污名的修正：一项减少污名干预措施的系统综述性研究
Alison Warren,Zan Wynia
Alison Warren
[This corrects the article DOI: 10.3389/frdem.2025.1601462.]. Keywords: Alzheimer's disease; bias; dementia;...
Published Erratum
Frontiers in dementia. 2025 Sep 29:4:1678458. DOI:10.3389/frdem.2025.1678458 2025
Editorial: Methods of engagement of dementia care users in research and practice development [0.03%]
编辑来稿：痴呆照护服务对象参与研究和实务发展之策略
W George Kernohan,Suzanne Timmons,Anthea Innes et al.
W George Kernohan et al.
Editorial: Neurocognitive disorders in the community: a global perspective [0.03%]
述评：从全球角度看社区中的神经认知障碍
Panagiotis Alexopoulos,Katherine Lawler,Chukwuanugo Ogbuagu et al.
Panagiotis Alexopoulos et al.
Intersectional research on dementia care for post-migrants and ethnic minority groups: a scoping review [0.03%]
移民及少数族裔长者的认知障碍照护：系统综述研究
Kübra Altinok,Seda Güney,Bugse Yüceer et al.
Kübra Altinok et al.
Objective: The aim of this scoping review is to identify the range, extent and nature of evidence available in peer-reviewed and gray literature and to examine how the intersecting experiences and differences of post-migr...
Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment [0.03%]
幻觉物质与人类脑类器官：蛋白质组学的见解及其潜在的阿尔茨海默病治疗作用
Xenia Androni,Rachel J Boyd,Paul B Rosenberg et al.
Xenia Androni et al.
Alzheimer's disease (AD) is characterized by a long preclinical phase lasting more than a decade before the onset of its clinical phase of mild cognitive impairment (MCI) or dementia. Recent advances in psychedelic research underscore numer...
Three-dimensional organotypic mouse brain slices to study Alzheimer's disease pathologies: a review [0.03%]
用于研究阿尔茨海默病病理的三维器官型小鼠脑切片：综述
Christian Humpel
Christian Humpel
Alzheimer's disease (AD) is a severe neurodegenerative brain disorder molecularly characterized by extracellular β-amyloid plaques, intraneuronal tau neurofibrillary tangles, cholinergic neuron death, neuroinflammation, vascular damage, an...
Dementia-related stigma in physicians: a scoping review of stigma-reduction interventions [0.03%]
与医师有关的痴呆症相关污名：减少污名干预措施的范畴审查
Alison Warren,Zan Wynia
Alison Warren
Introduction: Despite progress in dementia diagnosis and treatment, physician-held stigma remains a significant barrier to early recognition and effective care. Stigmatizing attitudes among healthcare professionals can ne...
Evidence that cholinergic mechanisms contribute to hyperexcitability at early stages in Alzheimer's disease [0.03%]
胆碱能机制参与阿尔茨海默病早期阶段的高兴奋性现象的证据
Helen E Scharfman,Korey Kam,Áine M Duffy et al.
Helen E Scharfman et al.
A long-standing theory for Alzheimer's disease (AD) has been that deterioration of synapses and depressed neuronal activity is a major contributing factor. We review the increasing evidence, in humans and in mouse models, that show that the...